Brief: Index Pharmaceuticals Gets Patent For Cobitolimod in US
Nov 9 (Reuters) - InDex Pharmaceuticals Holding AB
INDEX.ST :
* INDEX PHARMACEUTICALS GETS NEW PATENT FOR COBITOLIMOD
GRANTED IN
THE US
* PATENT WILL PROVIDE AN EXCLUSIVITY PERIOD UNTIL MAY 2038
Source text for Eikon: ID:nWkr7WrH9S
Further company coverage: INDEX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))
Recent news on Flerie AB
See all newsBrief: Flerie Q3 Net Asset Value SEK 3,113 Million
Brief: Flerie Portfolio Co Reports Positive Data From Clinical Proof-Of-Mechanism Study
Brief: Flerie Writes Down Value Of Holding In Empros Pharma
Brief: Nasdaq Approves Biosergen's Delisting Application
Brief: Flerie Approves Merger Plan For Flerie And Biosergen